אקטיליז 50 מג

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

ALTEPLASE

Commercializzato da:

BOEHRINGER INGELHEIM ISRAEL LTD.

Codice ATC:

B01AD

Forma farmaceutica:

אבקה וממס להכנת תמיסה להזרקה\אינפוזיה

Composizione:

ALTEPLASE 50 MG/VIAL

Via di somministrazione:

תוך-ורידי

Tipo di ricetta:

מרשם נדרש

Prodotto da:

BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY

Gruppo terapeutico:

ENZYMES

Indicazioni terapeutiche:

Acute myocardial infarction in adults for the lysis of thrombi obstructing coronary arteries the improvement of ventricular function and reduction of the incidence of congestive heart failure. Pulmonary embolism with hemodynamic deprivation. For fibrinolytic treatment of acute ischaemic stroke. Treatment must be started within 3 hours of onset of the stroke symptoms and after prior exclusion of intracranial haemorrhage by means of appropriate imaging techniques.This treatment is restricted to a prescription by aspecialist in neurology.

Data dell'autorizzazione:

2015-02-28